1800PetMeds competitors

Since 1989, Stanley M. Bergman has been Chairman of the Board and CEO of Henry Schein, Inc., a Fortune 500® company and the world's largest provider of health care products and services to office-based dental and medical practitioners, with more than 18,000 Team Schein Members and operations or affiliates in 31 countries. Henry Schein is a member of the S&P 500® and Nasdaq 100® indexes. In 2018, the Company's sales reached $9.4 billion from continuing operations. Henry Schein has been a Fortune World's Most Admired Company for 17 years. Mr. Bergman serves as a board member or advisor for numerous institutions including New York University College of Dentistry; the University of Pennsylvania School of Dental Medicine; the Columbia University Medical Center; University of the People; Hebrew University; Tel Aviv University; the University of the Witwatersrand Fund; The World Economic Forum’s Health Care Governors; the Business Council for International Understanding, the Japan Society and the Metropolitan Opera. Mr. Bergman is an honorary member of the American Dental Association and the Alpha Omega Dental Fraternity. Mr. Bergman is the recipient of the Ellis Island Medal of Honor; the CR Magazine Corporate Responsibility Lifetime Achievement Award; the 2017 CEO of the Year award by Chief Executive Magazine; Honorary Doctorates from The University of the Witwatersrand, Western University of Health Sciences, Hofstra University, A.T. Still University’s Arizona School of Dentistry and Oral Health, Case Western Reserve University and Farmingdale State College (SUNY); and Honorary Fellowship from King’s College London - Dental Institute and the International College of Dentists.

Tyler has more than two decades of experience with McKesson, having served in a wide variety of leadership roles throughout the company. He has led nearly every major business within the company as well as McKesson’s corporate strategy and business development unit.

Ed was named president & chief executive officer of Owens & Minor, effective March 7, 2019, and was appointed to the board of directors at the same time. Prior to that, Ed served as an independent consultant and advisor in the healthcare, life science and distribution industries since January 2016. From January 2000 through April 2015, he served in various roles of increasing responsibility at Thermo Fisher Scientific, a $17 billion manufacturer and supplier of a range of products to the research, healthcare, industrial and safety markets, including most recently as chief commercial officer & senior vice president. Before joining Thermo Fisher Scientific, Ed spent eight years at TRW Inc., in a variety of finance roles and three years with PricewaterhouseCoopers as an auditor.

Founder of Sirius XM radio and United Therapeutics. Progressive technologist and green energy advocate. Helicopter, fixed wing pilot.

Marcio C Cabrera is a Board Member at Medical Specialties Distri LLC, Managing Director at MBF Healthcare Management LLC, and Managing Director at MBF Healthcare Partners. He has worked as Exec VP/CFO/Secretary at RAMSAY YOUTH SERVICES and Exec VP/CFO/Secretary at Ramsay Health Care UK. Marcio works or has worked at Deloitte & Touche LLP and works or has worked as Board Member at Navarro Discount Pharmacy. He attended University of Miami.